|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Glucagon Replacement via Micro-Osmotic Pump Corrects Hypoglycemia and 
-Cell Hyperplasia in Prohormone Convertase 2 Knockout Mice
1 Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois
2 Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois
3 Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois
Prohormone convertase 2 (PC2) plays an essential role in the processing of proglucagon to mature active glucagon in pancreatic 
-cells (J Biol Chem 276:27197–27202, 2001). Mice lacking PC2 demonstrate multiple defects, including chronic mild hypoglycemia and dramatic hyperplasia of the pancreatic -cells. To define the contribution of mature glucagon deficiency to the hypoglycemia and -cell hyperplasia, we have attempted to correct the defects by delivery of exogenous glucagon by micro-osmotic pumps. Intraperitoneal delivery of 0.5 µg glucagon/h in PC2-/- mice resulted in the normalization of blood glucose concentrations. Islet remodeling through the loss of hyperplastic -cells was evident by day 11 after pump implantation; by 25 days postimplantation, PC2-/- islets were indistinguishable from wild-type islets. These rapid changes were brought about by induction of apoptosis in the -cell population. Morphological normalization of islets was also accompanied by marked downregulation of endogenous preproglucagon gene expression, but with little or no change in the level of preproinsulin gene expression. Exogenous glucagon delivery also normalized hepatic expression of the gluconeogenic enzyme PEPCK. These results demonstrate that the lack of mature glucagon in PC2-/- mice is responsible for the aberrant blood glucose levels, islet morphology, and gene expression, and they confirm the role of glucagon as a tonic insulin antagonist in regulating glycemia.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  R. D. Wideman, S. D. Covey, G. C. Webb, D. J. Drucker, and T. J. Kieffer A Switch From Prohormone Convertase (PC)-2 to PC1/3 Expression in Transplanted {alpha}-Cells Is Accompanied by Differential Processing of Proglucagon and Improved Glucose Homeostasis in Mice Diabetes, November 1, 2007; 56(11): 2744 - 2752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bollyky and C. J. Greenbaum The Role of Glucagon in Postprandial Hyperglycemia The Jury's Still Out J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2879 - 2881. [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Dunning and J. E. Gerich The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications Endocr. Rev., May 1, 2007; 28(3): 253 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. Chen, Y. Zhang, T. S. Santomango, P. E. Williams, D. B. Lacy, and O. P. McGuinness Glucagon chronically impairs hepatic and muscle glucose disposal Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E928 - E935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Vuguin, M. H. Kedees, L. Cui, Y. Guz, R. W. Gelling, M. Nejathaim, M. J. Charron, and G. Teitelman Ablation of the Glucagon Receptor Gene Increases Fetal Lethality and Produces Alterations in Islet Development and Maturation Endocrinology, September 1, 2006; 147(9): 3995 - 4006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Raju and P. E. Cryer Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E181 - E186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Peinado, V. Laurent, S.-N. Lee, B. W. Peng, J. E. Pintar, D. F. Steiner, and I. Lindberg Strain-Dependent Influences on the Hypothalamo-Pituitary-Adrenal Axis Profoundly Affect the 7B2 and PC2 Null Phenotypes Endocrinology, August 1, 2005; 146(8): 3438 - 3444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Webb, A. Dey, J. Wang, J. Stein, M. Milewski, and D. F. Steiner Altered Proglucagon Processing in an {alpha}-Cell Line Derived from Prohormone Convertase 2 Null Mouse Islets J. Biol. Chem., July 23, 2004; 279(30): 31068 - 31075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vincent, Y. Guz, M. Rozenberg, G. Webb, M. Furuta, D. Steiner, and G. Teitelman Abrogation of Protein Convertase 2 Activity Results in Delayed Islet Cell Differentiation and Maturation, Increased {alpha}-Cell Proliferation, and Islet Neogenesis Endocrinology, September 1, 2003; 144(9): 4061 - 4069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, Y. Cao, and D. F. Steiner Regulation of Proglucagon Transcription by Activated Transcription Factor (ATF) 3 and a Novel Isoform, ATF3b, through the cAMP-response Element/ATF Site of the Proglucagon Gene Promoter J. Biol. Chem., August 29, 2003; 278(35): 32899 - 32904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS Curbing activation: proprotein convertases in homeostasis and pathology FASEB J, July 1, 2003; 17(10): 1215 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jiang and B. B. Zhang Glucagon and regulation of glucose metabolism Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E671 - E678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Gelling, X. Q. Du, D. S. Dichmann, J. Romer, H. Huang, L. Cui, S. Obici, B. Tang, J. J. Holst, C. Fledelius, et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice PNAS, February 4, 2003; 100(3): 1438 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhu, L. Orci, R. Carroll, C. Norrbom, M. Ravazzola, and D. F. Steiner Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3 PNAS, August 6, 2002; 99(16): 10299 - 10304. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |